4'-Methoxycarbonylbenzo-15-crown 5-ether

CAS: 56683-56-8

Ref. 3D-FM62091

Produktinformation

• Name: 4'-Methoxycarbonylbenzo-15-crown 5-ether
• Synonyme: 2,3-(4-Methoxycarbonylbenzo)-1,4,7,10,13-pentaoxacyclopentadec-2-ene
• Marke: Biosynth
• Beschreibung: 4'-Methoxycarbonylbenzo-15-crown 5-ether (4MBC) is a gestational, microstructural, extracellular and thermodynamic teratogen that has been shown to have a high level of resistance to hyaluronidase. 4MBC binds to hyaluronic acid, which is a component of the synovial fluid in the joints. The binding of 4MBC to hyaluronic acid results in inhibition of cartilage growth, which leads to joint degradation. This drug also has been shown to cause fetal bovine serum proteins to precipitate. 4MBC is associated with an increased risk for body mass index (BMI) greater than 30 kg/m2 and an increased risk of radiofrequency ablation (RFA) for benign uterine masses.

Chemische Eigenschaften

• Molekulargewicht: 326.34 g/mol
• Formel: C₁₆H₂₂O₇
• Reinheit: Min. 95%
• Farbe/Form: White Powder
• InChl: InChI=1S/C16H22O7/c1-18-16(17)13-2-3-14-15(12-13)23-11-9-21-7-5-19-4-6-20-8-10-22-14/h2-3,12H,4-11H2,1H3
• InChI Key: InChIKey=PMGUUVHWCHSZKY-UHFFFAOYSA-N
• SMILES: COC(=O)c1ccc2c(c1)OCCOCCOCCOCCO2